Company Filing History:
Years Active: 2018
Title: Ann Marie Ocampo Francisco: Innovator in Insulin Administration
Introduction
Ann Marie Ocampo Francisco is a notable inventor based in Copenhagen, Denmark. She has made significant contributions to the field of medical technology, particularly in the treatment of diseases requiring insulin administration. Her innovative approach has the potential to improve the lives of many individuals managing diabetes.
Latest Patents
Ann Marie holds a patent for an invention titled "Administration regime." This invention relates to a novel administration regime useful in the treatment of diseases or conditions where the administration of insulin will be beneficial. The patent describes a long-acting or ultra-long-acting insulin for use in treating conditions that require insulin. The administration process involves several steps, including optionally providing a blood sample, taking a single fasting blood glucose measurement, determining the insulin dose based on that measurement, and administering the insulin at the determined dose.
Career Highlights
Ann Marie is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has allowed her to focus on innovative solutions that enhance insulin delivery and management for patients. With her expertise, she has contributed to advancements in diabetes treatment protocols.
Collaborations
Throughout her career, Ann Marie has collaborated with esteemed colleagues such as Thue Johansen and Torsten Christensen. These collaborations have fostered a productive environment for innovation and have led to significant advancements in the field of insulin administration.
Conclusion
Ann Marie Ocampo Francisco is a pioneering inventor whose work in insulin administration has the potential to transform diabetes treatment. Her innovative patent and contributions at Novo Nordisk highlight her commitment to improving patient care.